Wall Street Legend: The Top 11 Stocks for 2023 📈

[Image](www.elitetrade.club) Good Morning! Hey, there! It's Chris from Elite Trade Club, here to give you this morning's premarket trading news. It's Wednesday, January 4th. I hope you have a great day. Let's get ready to trade! Markets 📈 The stock market stumbled in the first trading session of the new year. The S&P 500 lost 0.4%, and the Nasdaq fell 0.7%. The Dow posted a fractional loss of less than 0.1%, and the small-cap Russell 2K slid 0.6%. This morning, futures are up in early morning trading. S&P 500 contracts are currently showing a 0.3% gain. Sponsored [Wall Street Legend: The Top 11 Stocks for 2023]( 📈 Louis Navellier’s system has identified 18 stocks that rose 10,000% or higher... And, more than 675 stocks that went up 100%... Not to mention the No. 1 stock in the S&P 500 each and every year, for a decade, from 2012 to 2021. Now he’s releasing his list of the Top 11 stocks for 2023. [Click here to get this list for free.]( Premarket Highlights 🔎 💵 Dollar Falls: The WSJ Dollar Index is down 0.8% after the Australian dollar, British pound, and Japanese yen all gained against the US currency. Major Earnings 💰 Unifirst Corporation [UNF] ... AM Simulations Plus, Inc. [SLP] ... PM Resources Connection, Inc. [RGP] ... PM Richardson Electronics, Ltd. [RELL] ... PM Economy 🏗 - ISM manufacturing index [Dec] ... 10a - Job openings [Nov] ... 10a - Quits [Nov] ... 10a - Motor vehicle sales (SAAR) [Dec] ... Varies Running Hot 🔥 Gainers - Tenax Therapeutics [TENX] >> +64.1% - Atlis Motor Vehicle [AMV] >> +45.3% - Elys Game Technology [ELYS] >> +24.3% Decliners - Vera Therapeutics [VERA] >> (60.3%) - Enovix [ENVX] >> (38.2%) - Lucira Health [LHDX] >> (30.1%) Micron Technology [MU] - Last Close: $50.37 Micron is moving higher on an analyst upgrade. In Tuesday's aftermarket, analysts at UBS raised its price target on the chipmaker's stock from $70 to $75 and maintained its "buy" rating. According to analysts polled by Capital IQ, MU has an average rating of "outperform" with price targets ranging from $45 to $100. The price target hike seems to be giving the stock a boost this morning. MU is leading the S&P 500 with a 3.8% gain on active premarket volume. My Take: MU struggled through most of 2022, but it could finally be bottoming out. It looks like a double-bottom is developing in the chart, so there could be a breakout in the cards in the for this stock. Doubledown Interactive [DDI] - Last Close: $8.18 Doubledown Interactive is rallying after an early morning announcement. The Korea-based video game company said it would participate in the upcoming 25th Annual Needham Growth Conference in New York City. The conference will be held Jan. 10th through Jan. 12th, 2023, at The Lotte New York Palace in NYC. Doubledown's management will host one-on-one meetings with potential investors during the even, and the company will present on Jan. 10th at 4:30 p.m. DDI is one of this morning's top premarket performers, with a 119.4% gain on news of its conference participation. My Take: This move seems a little overdone, but DDI has a low short percentage of just 0.02%. It could be a "buy the rumor" scenario, but I expect we'll see a big pullback before the conference actually starts on Jan. 10th. Geron Corp. [GERN] - Last Close: $2.40 Positive clinical data is lifting shares of Geron Corp. The late-stage biotech firm reported positive top-line results from an Imerge Phase 3 trial of imetelstat in lower-risk MDS patients. Geron said the drug produced significant and clinically meaningful efficacy results across several key MDS subtypes. The company says it now expected to submit a new drug application to the US Food & Drug Administration in mid-2023. It's also planning on submitting a marketing authorization application in the European Union sometime in the second half of the year. GERN is one of today's top movers, and it's up 54.5% on the news. My Take: GERN seems to be on course for a full drug approval this year, but a large portion of the gains are probably priced in after today's rally. However, there could be a swing trade opportunity if shares pullback before an approval comes. Vivos Therapeutics [VVOS] - Last Close: $0.74 Vivos Therapeutics is moving higher on news of a drug approval. The MedTech company announced the U.S. FDA awarded 510(k) clearance for its proprietary DNA appliance, or daytime-nighttime appliance. The Class II device gives obstructive sleep apnea patients a new treatment option, and Vivos says it anticipates increased ease of adoption. VVOS is one of today's top stocks with a 66.2% gain on the news. My Take: VVOS mysteriously gained 84.0% on Tuesday, well before this story broke. Now it's up another 66.2% in the premarket. It certainly looks like there were some big buyers who were tipped off ahead of this news. That's it for today! Thanks for reading, and good luck out there! Best Regards, Chris D. -- Elite Trade Club P.S... If you're on the hunt for a new broker, check out our preferred partner, moomoo! You can [get 15 free stocks]( worth up to $2,000 each if you join the moomoo App now. [Click here to get started.]( P.P.S... Want alerts delivered straight to your cell every morning for free?* Text ELITE to 47121 or [click here]( to sign up now and get our watchlists sent directly to your phone! Or text CLOSE to 47121 to get on the mobile alert list for our Closing Bell Roundup report, featuring the day's top winners and losers. *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](